This is not an all-inclusive list of Clinical Trials that are available at Clinic Cancer Care. If you have questions about a Clinical Trial on the website or one you have heard about, please feel free to call the Clinical Research Department at (406) 454-2171. Thank you.

Clinic Cancer Care actively participates on a national level in clinical research trials. Once patients have been fully informed of the potential risks and rewards, they are provided with the opportunity to participate in appropriate clinical trial programs. These trials incorporate state-of-the-art patient care, while evaluating the best way to apply the most recent breakthroughs in cancer medicine. Before a treatment can be tested on our patients, it first must be deemed safe in other laboratory studies.

Treatment Clinical Trials
These trials are for people who have cancer.

Prevention Clinical Trials
This trial finds ways to prevent the occurrence of cancer or lower chances of getting cancer.

Supportive Care Clinical Trials
Addresses the side effects patients develop from chemotherapy and radiation treatments: nausea, pain control, weight loss, quality of life issues, etc.

• A small number of patients.
• Investigators determine the most effective dosage and application methods.
• It's an opportunity to be one of the first to receive treatments that are being newly introduced.

• Involves a larger group of patients.
• Investigators usually determine the common short term side effects and risks associated with the drug/treatment.

• Thousands of patients involved, and several medical institutions.
• Some patients, the "treatment group", are given experimental treatments.
• Others, in the "control group" are given standard treatment protocols, so further research can compare the two outcomes.

• Trials occur after the treatment has been introduced to the market to monitor usage, long term effects and how it affects certain demographics.

According to the National Cancer Institute, studying cancer drugs and their effects during Phase 1-3 trials usually takes an average of 9 to 10 years. Patients who choose to participate may or may not receive a benefit beyond what they could have received through standard care, but their active participation will bring us additional information on the disease and a possible cure for the future.